XBiotech (XBIT) Financials

$2.20

$0.00 (0.00%)

As on 04-Sep-2026 16:02EDT

Market cap

$67 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-39.92	-30.96	-18.73	-14.82	69.45
Cash Flow from Investing Activities	--	-0.29	-1.30	61.50	-63.89	-3.53
Cash from Financing Activities	--	-10.25	10.45	-0.01	0.03	-67.01
Net Cash Inflow / Outflow	--	--	--	--	-78.72	-1.09

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.48	-1.49	-1.26	-0.81	-1.08	-0.57
Cash EPS ($)	--	-1.44	-1.21	-0.75	-0.99	-0.49
Adjusted Book Value ($)	--	4.60	5.98	7.19	7.90	8.88
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.31	-1.02	-0.62	-0.49	2.29
Free Cash Flow per Share ($)	--	-1.32	-1.06	-0.63	-0.51	2.17

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-27.36	-18.73	-10.69	-12.91	-5.64
ROE (%)	-33.58	-28.23	-19.21	-10.69	-12.91	-5.64
ROA (%)	-28.25	-26.08	-18.10	-10.39	-12.62	-5.54
EBIT Margin (%)	--	--	--	-8,104.33	-837.61	-138.40
Net Margin (%)	--	--	--	-8,185.67	-669.79	-96.65
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	-0.93	-0.78	-0.58
EBIT Growth (%)	-38.11	-19.76	-55.29	27.61	-31.93	-39.30
Net Profit Growth (%)	-60.26	-18.19	-56.90	25.36	-88.93	-55.19
EPS Growth (%)	-60.19	-0.18	-0.57	0.25	-0.88	-0.50
Book Value Growth (%)	-25.77	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.60	-3.12	-4.96	-3.25	-19.39
Price / Book Value	0.53	0.52	0.66	0.56	0.44	1.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.60	1.21	1.17	3.47	3.57	-4.42
Close Price ($)	2.30	2.39	3.95	4.00	3.51	11.13
High Price ($)	3.61	4.67	9.96	6.69	11.90	20.75
Low Price ($)	2.09	2.09	3.51	3.05	3.00	10.71
Market Cap ($ Cr)	67.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.06	--	--	--
Short term debt to equity ratio	--	--	0.06	--	--	--
Current Ratio	33.15	16.01	11.56	33.07	54.07	71.49
Quick Ratio	33.15	--	--	--	--	74.09
Interest Coverage	--	-513.83	-46.79	--	-37.24	-23.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	311.67	43.99	48.67
Asset Turnover	--	--	--	0.00	0.02	0.06
Receivable days	--	--	--	1,643.02	488.08	129.73
Inventory Days	--	--	--	--	-5,023.17	-487.22
Payable days	--	407.06	495.97	515.62	1,255.93	143.09
Cash Conversion Cycle	--	--	--	--	-5,791.02	-500.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.